Abstract
The aim of this study was to investigate pertussis-specific cell-mediated immunity in infants vaccinated with a tricomponent acellular vaccine. Infants were investigated during a primary vaccination schedule from the third month of life to the sixth month as well as before and after a booster at 15 to 24 months. This is the first report of specific cell-mediated immune responses to pertussis-related antigens in infants below the age of 12 months. Our data show that the vaccine induces T-cell responses specific for the vaccine components, detoxified pertussis toxin, filamentous hemagglutinin, and pertactin, that increase progressively over the course of the vaccination schedule. In contrast to declining antibody titers, cell-mediated immune responses are stable over the postprimary to prebooster period. Vaccination results in a progressive increase in the number of T cells that express activation marker CD45RO preferentially on CD4-positive T cells after stimulation with pertussis antigens. Measurements of cytokine secretion profiles demonstrated a preferential induction of interleukin 2- and gamma interferon-producing T-helper 1 cells and only low production of interleukin 10. The observed persistence of the specific cell-mediated immunity may have a bearing on the protective mechanisms induced by pertussis vaccination. Cell-mediated immunity requires further study, particularly to improve our understanding of the persistence of protection afforded by vaccination up to the administration of booster doses.
Full Text
The Full Text of this article is available as a PDF (243.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adamson P. C., Wu T. C., Meade B. D., Rubin M., Manclark C. R., Pizzo P. A. Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr. 1989 Oct;115(4):589–592. doi: 10.1016/s0022-3476(89)80288-4. [DOI] [PubMed] [Google Scholar]
- Anderson E. L., Belshe R. B., Bartram J. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. J Infect Dis. 1988 Apr;157(4):731–737. doi: 10.1093/infdis/157.4.731. [DOI] [PubMed] [Google Scholar]
- Arciniega J. L., Shahin R. D., Burnette W. N., Bartley T. D., Whiteley D. W., Mar V. L., Burns D. L. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin. Infect Immun. 1991 Oct;59(10):3407–3410. doi: 10.1128/iai.59.10.3407-3410.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baraff L. J., Cody C. L., Cherry J. D. DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics. 1984 Jan;73(1):31–36. [PubMed] [Google Scholar]
- Bottomly K. A functional dichotomy in CD4+ T lymphocytes. Immunol Today. 1988 Sep;9(9):268–274. doi: 10.1016/0167-5699(88)91308-4. [DOI] [PubMed] [Google Scholar]
- Bromberg K., Tannis G., Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect Immun. 1991 Dec;59(12):4715–4719. doi: 10.1128/iai.59.12.4715-4719.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burstyn D. G., Baraff L. J., Peppler M. S., Leake R. D., St Geme J., Jr, Manclark C. R. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun. 1983 Sep;41(3):1150–1156. doi: 10.1128/iai.41.3.1150-1156.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cahill E. S., O'Hagan D. T., Illum L., Barnard A., Mills K. H., Redhead K. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine. 1995 Apr;13(5):455–462. doi: 10.1016/0264-410x(94)00008-b. [DOI] [PubMed] [Google Scholar]
- Charles I. G., Li J. L., Roberts M., Beesley K., Romanos M., Pickard D. J., Francis M., Campbell D., Dougan G., Brennan M. J. Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur J Immunol. 1991 May;21(5):1147–1153. doi: 10.1002/eji.1830210509. [DOI] [PubMed] [Google Scholar]
- Chong P., Zobrist G., Sia C., Loosmore S., Klein M. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides. Infect Immun. 1992 Nov;60(11):4640–4647. doi: 10.1128/iai.60.11.4640-4647.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Magistris M. T., Rappuoli R., Tagliabue A. Human T cell immunity against Bordetella pertussis analyzed at clonal level. Ann Ist Super Sanita. 1991;27(1):33–36. [PubMed] [Google Scholar]
- De Magistris M. T., Romano M., Bartoloni A., Rappuoli R., Tagliabue A. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med. 1989 May 1;169(5):1519–1532. doi: 10.1084/jem.169.5.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Magistris M. T., Romano M., Nuti S., Rappuoli R., Tagliabue A. Dissecting human T cell responses against Bordetella species. J Exp Med. 1988 Oct 1;168(4):1351–1362. doi: 10.1084/jem.168.4.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edwards K. M., Decker M. D. Acellular pertussis vaccines for infants. N Engl J Med. 1996 Feb 8;334(6):391–392. doi: 10.1056/NEJM199602083340609. [DOI] [PubMed] [Google Scholar]
- Ewanowich C. A., Melton A. R., Weiss A. A., Sherburne R. K., Peppler M. S. Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun. 1989 Sep;57(9):2698–2704. doi: 10.1128/iai.57.9.2698-2704.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gearing A. J., Bird C. R., Redhead K., Thomas M. Human cellular immune responses to Bordetella pertussis infection. FEMS Microbiol Immunol. 1989 Mar;1(4):205–211. doi: 10.1111/j.1574-6968.1989.tb02384.x. [DOI] [PubMed] [Google Scholar]
- Gray D. Immunological memory. Annu Rev Immunol. 1993;11:49–77. doi: 10.1146/annurev.iy.11.040193.000405. [DOI] [PubMed] [Google Scholar]
- Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A. E., Anemona A., Ciofi degli Atti M. L., Giammanco A., Panei P., Blackwelder W. C. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med. 1996 Feb 8;334(6):341–348. doi: 10.1056/NEJM199602083340601. [DOI] [PubMed] [Google Scholar]
- Grob P. R., Crowder M. J., Robbins J. F. Effect of vaccination on severity and dissemination of whooping cough. Br Med J (Clin Res Ed) 1981 Jun 13;282(6280):1925–1928. doi: 10.1136/bmj.282.6280.1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gustafsson L., Hallander H. O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996 Feb 8;334(6):349–355. doi: 10.1056/NEJM199602083340602. [DOI] [PubMed] [Google Scholar]
- Johannisson A., Festin R. Phenotype transition of CD4+ T cells from CD45RA to CD45R0 is accompanied by cell activation and proliferation. Cytometry. 1995 Apr 1;19(4):343–352. doi: 10.1002/cyto.990190409. [DOI] [PubMed] [Google Scholar]
- Jones D. H., McBride B. W., Jeffery H., O'Hagan D. T., Robinson A., Farrar G. H. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine. 1995 May;13(7):675–681. doi: 10.1016/0264-410x(95)99876-j. [DOI] [PubMed] [Google Scholar]
- Kaufmann S. H. Immunity to intracellular microbial pathogens. Immunol Today. 1995 Jul;16(7):338–342. doi: 10.1016/0167-5699(95)80151-0. [DOI] [PubMed] [Google Scholar]
- Kimura A., Mountzouros K. T., Relman D. A., Falkow S., Cowell J. L. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun. 1990 Jan;58(1):7–16. doi: 10.1128/iai.58.1.7-16.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mills K. H., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun. 1993 Feb;61(2):399–410. doi: 10.1128/iai.61.2.399-410.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morse J. H., Kong A. S., Lindenbaum J., Morse S. I. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes. J Clin Invest. 1977 Sep;60(3):683–692. doi: 10.1172/JCI108820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mosmann T. R., Coffman R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111–147. doi: 10.1016/s0065-2776(08)60652-5. [DOI] [PubMed] [Google Scholar]
- Novotny P., Macaulay M. E., Hart T. C., Skvaril F. Analysis of antibody profiles in children with whooping cough. Dev Biol Stand. 1991;73:267–273. [PubMed] [Google Scholar]
- Olander R. M., Muotiala A., Karvonen M., Kuronen T., Runeberg-Nyman K. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model. Microb Pathog. 1990 Jan;8(1):37–45. doi: 10.1016/0882-4010(90)90006-c. [DOI] [PubMed] [Google Scholar]
- Peppoloni S., Nencioni L., Di Tommaso A., Tagliabue A., Parronchi P., Romagnani S., Rappuoli R., De Magistris M. T. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun. 1991 Oct;59(10):3768–3773. doi: 10.1128/iai.59.10.3768-3773.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petersen J. W., Andersen P., Ibsen P. H., Capiau C., Wachmann C. H., Hasløv K., Heron I. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine. 1993;11(4):463–472. doi: 10.1016/0264-410x(93)90289-a. [DOI] [PubMed] [Google Scholar]
- Petersen J. W., Holm A., Ibsen P. H., Hasløv K., Heron I. Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun. 1993 Jan;61(1):56–63. doi: 10.1128/iai.61.1.56-63.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petersen J. W., Ibsen P. H., Bentzon M. W., Capiau C., Heron I. The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol. 1991 Oct;3(5):279–287. doi: 10.1111/j.1574-6968.1991.tb04224.x. [DOI] [PubMed] [Google Scholar]
- Petersen J. W., Ibsen P. H., Hasløv K., Heron I. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun. 1992 Nov;60(11):4563–4570. doi: 10.1128/iai.60.11.4563-4570.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Podda A., Nencioni L., De Magistris M. T., Di Tommaso A., Bossù P., Nuti S., Pileri P., Peppoloni S., Bugnoli M., Ruggiero P. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med. 1990 Sep 1;172(3):861–868. doi: 10.1084/jem.172.3.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollock T. M., Miller E., Mortimer J. Y., Smith G. Symptoms after primary immunisation with DTP and with DT vaccine. Lancet. 1984 Jul 21;2(8395):146–149. doi: 10.1016/s0140-6736(84)91057-2. [DOI] [PubMed] [Google Scholar]
- Redhead K., Watkins J., Barnard A., Mills K. H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun. 1993 Aug;61(8):3190–3198. doi: 10.1128/iai.61.8.3190-3198.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson A., Irons L. I., Ashworth L. A. Pertussis vaccine: present status and future prospects. Vaccine. 1985 Mar;3(1):11–22. doi: 10.1016/0264-410x(85)90004-0. [DOI] [PubMed] [Google Scholar]
- Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today. 1991 Aug;12(8):256–257. doi: 10.1016/0167-5699(91)90120-I. [DOI] [PubMed] [Google Scholar]
- Ruuskanen O., Noel A., Putto-Laurila A., Pêtre J., Capiau C., Delem A., Vandevoorde D., Simoen E., Teuwen D. E., Bogaerts H. Development of an acellular pertussis vaccine and its administration as a booster in healthy adults. Vaccine. 1991 Feb;9(2):117–121. doi: 10.1016/0264-410x(91)90267-a. [DOI] [PubMed] [Google Scholar]
- Sato H., Sato Y., Ohishi I. Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies. Infect Immun. 1991 Oct;59(10):3832–3835. doi: 10.1128/iai.59.10.3832-3835.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sato Y., Sato H. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children. Dev Biol Stand. 1985;61:367–372. [PubMed] [Google Scholar]
- Saukkonen K., Cabellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med. 1991 May 1;173(5):1143–1149. doi: 10.1084/jem.173.5.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmitt H. J., von König C. H., Neiss A., Bogaerts H., Bock H. L., Schulte-Wissermann H., Gahr M., Schult R., Folkens J. U., Rauh W. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA. 1996 Jan 3;275(1):37–41. [PubMed] [Google Scholar]
- Shahin R. D., Brennan M. J., Li Z. M., Meade B. D., Manclark C. R. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med. 1990 Jan 1;171(1):63–73. doi: 10.1084/jem.171.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas M. G., Redhead K., Lambert H. P. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J Infect Dis. 1989 Feb;159(2):211–218. doi: 10.1093/infdis/159.2.211. [DOI] [PubMed] [Google Scholar]
- Tomoda T., Ogura H., Kurashige T. Immune responses to Bordetella pertussis infection and vaccination. J Infect Dis. 1991 Mar;163(3):559–563. doi: 10.1093/infdis/163.3.559. [DOI] [PubMed] [Google Scholar]